![](/img/cover-not-exists.png)
How many tumor indications should be initially screened in development of next generation immunotherapies?
Chen, Cong, Deng, Qiqi, He, Linchen, Mehrotra, Devan, Rubin, Eric H., Beckman, Robert A.Language:
english
Journal:
Contemporary Clinical Trials
DOI:
10.1016/j.cct.2017.03.012
Date:
March, 2017
File:
PDF, 496 KB
english, 2017